{"created":"2023-08-02T03:58:31.506971+00:00","id":7684,"links":{},"metadata":{"_buckets":{"deposit":"c2a07709-de45-4c6c-975f-ea7dbbafc2a6"},"_deposit":{"created_by":10,"id":"7684","owners":[10],"pid":{"revision_id":0,"type":"depid","value":"7684"},"status":"published"},"_oai":{"id":"oai:repository.lib.tottori-u.ac.jp:00007684","sets":["1:9","2:14","23:40:1123:1124"]},"author_link":["3446","1082"],"item_3_alternative_title_31":{"attribute_name":"タイトル（ヨミ）","attribute_value_mlt":[{"subitem_alternative_title":"ＤＩＣ　オ　サイコウ　スル　：　ナゼ　ベイコク　デワ　ＤＩＣ　オ　チリョウ　シナイ　ノカ","subitem_alternative_title_language":"ja-Kana"}]},"item_3_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-05-31","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-3","bibliographicPageEnd":"21","bibliographicPageStart":"10","bibliographicVolumeNumber":"74","bibliographic_titles":[{"bibliographic_title":"米子医学雑誌","bibliographic_titleLang":"ja"},{"bibliographic_title":"The Journal of the Yonago Medical Association","bibliographic_titleLang":"en"}]}]},"item_3_description_4":{"attribute_name":"著者ID","attribute_value_mlt":[{"subitem_description":"03446","subitem_description_type":"Other"},{"subitem_description":"01082","subitem_description_type":"Other"}]},"item_3_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The clinical management for disseminated intravascular coagulation （DIC） is quite different from overseas. In Japan, once a clinician diagnoses DIC, antithrombin III （AT-III） or recombinant thrombomodulin（ rh-TM） is usually administered; however, in the United States, no specific medication is used for DIC. The difference originated from the guidelines. There is no description of specific treatment for DIC in the global guidelines. Japanese researchers historically contributed to this field, and Japan has long been leading the establishment of clinical diagnostic criteria. Although there is no firm evidence of the treatment options, AT-III and rh-TM are weakly recommended in severe conditions in the Japanese guideline. The reason would be the difference in the concept of costeffectiveness between Japan and other countries. The global guidelines are intended to be used in any country regardless of economic background. Clinicians in Japan should pay more attention to patients’ eligibility for DIC treatment.","subitem_description_type":"Other"}]},"item_3_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"米子医学会"}]},"item_3_relation_16":{"attribute_name":"情報源","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"米子医学雑誌. 2023, 74(1-3), 10-21."}]}]},"item_3_rights_15":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"注があるものを除き、この著作物は日本国著作権法により保護されています。 / This work is protected under Japanese Copyright Law unless otherwise noted."}]},"item_3_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00247383","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00440558","subitem_source_identifier_type":"ISSN"}]},"item_3_text_32":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"鳥取大学医学部消化器・腎臓内科"},{"subitem_text_value":"鳥取大学医学部消化器・腎臓内科"}]},"item_3_text_33":{"attribute_name":"著者所属（英）","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Division of Medicine and Clinical Science, Department of Gastroenterology and Nephrology, School of Medicine, Tottori University Faculty of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Division of Medicine and Clinical Science, Department of Gastroenterology and Nephrology, School of Medicine, Tottori University Faculty of Medicine"}]},"item_3_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"杉原, 誉明"},{"creatorName":"スギハラ, タカアキ","creatorNameLang":"ja-Kana"},{"creatorName":"Sugihara, Takaaki","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"3446","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"60753853","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=60753853"},{"nameIdentifier":"100001245","nameIdentifierScheme":"研究者総覧鳥取大学","nameIdentifierURI":"http://researchers.adm.tottori-u.ac.jp/html/100001245_ja.html"}]},{"creatorNames":[{"creatorName":"磯本, 一"},{"creatorName":"イソモト, ハジメ","creatorNameLang":"ja-Kana"},{"creatorName":"Isomoto, Hajime","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1082","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"90322304","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=90322304"},{"nameIdentifier":"100001541","nameIdentifierScheme":"研究者総覧鳥取大学","nameIdentifierURI":"http://researchers.adm.tottori-u.ac.jp/html/100001541_ja.html"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-07-14"}],"displaytype":"detail","filename":"jyma74(1-3)_10.pdf","filesize":[{"value":"1.3 MB"}],"format":"application/pdf","licensefree":"注があるものを除き、この著作物は日本国著作権法により保護されています。 / This work is protected under Japanese Copyright Law unless otherwise noted.","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"jyma74(1-3)_10.pdf","url":"https://repository.lib.tottori-u.ac.jp/record/7684/files/jyma74(1-3)_10.pdf"},"version_id":"b1a1c8d1-ab00-40e9-9567-00e06eca3487"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Disseminated intravascular coagulation","subitem_subject_scheme":"Other"},{"subitem_subject":"Sepsis","subitem_subject_scheme":"Other"},{"subitem_subject":"Antithrombin activity","subitem_subject_scheme":"Other"},{"subitem_subject":"Systemic inflammatory response syndrome","subitem_subject_scheme":"Other"},{"subitem_subject":"Anticoagulant","subitem_subject_scheme":"Other"},{"subitem_subject":"Disseminated intravascular coagulation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Sepsis","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Antithrombin activity","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Systemic inflammatory response syndrome","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Anticoagulant","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"DICを再考する：なぜ米国ではDICを治療しないのか？","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"DICを再考する：なぜ米国ではDICを治療しないのか？","subitem_title_language":"ja"},{"subitem_title":"Rethink DIC: Why is DIC not treated in the USA?","subitem_title_language":"en"}]},"item_type_id":"3","owner":"10","path":["9","14","1124"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-07-14"},"publish_date":"2023-07-14","publish_status":"0","recid":"7684","relation_version_is_last":true,"title":["DICを再考する：なぜ米国ではDICを治療しないのか？"],"weko_creator_id":"10","weko_shared_id":-1},"updated":"2023-09-26T23:38:13.933733+00:00"}